Pain practice : the official journal of World Institute of Pain
-
Multicenter Study Clinical Trial
Efficacy, Safety, and Predictors of Intradiscal Methylene Blue Injection for Discogenic Low Back Pain: Results of a Multicenter Prospective Clinical Series.
Prospective clinical study of intradiscal methylene blue injection for the treatment of lumbar discogenic pain. ⋯ Our findings of 40% positive respondents, and no complications, give reason to set up a randomized, double-blind, placebo-controlled, trial.